OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-PARVA antibodies

Anti-PARVA CAPTURE Antibody Clone OTI1H2

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA600346 Luminex and ELISA validated PARVA mouse monoclonal antibody (clone 1H2, clone OTI1H2 (formerly 1H2) 100ug $325 2 Weeks
Matched Antibody
  • Luminex and ELISA validated biotinylated PARVA mouse monoclonal antibody (clone 3H2), clone OTI3H2 (formerly 3H2), 50 ug
TA700343 $345 3 Weeks Add to Shopping Cart
Add to Shopping Cart

spacer
LMNX(1)
ELISA(1)
spacer
Also for PARVA (NM_018222)
cDNA Clone shRNA/siRNA CRISPR KO Kit Protein Antibody

OriGene Data

ImmunogenFull length human recombinant protein of human PARVA (NM_018222) produced in HEK293T cell.
Clone NameClone OTI1H2 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application *ELISA, LMNX Suggested DilutionsELISA,LMNX
BufferStored in PBS (pH 7.4) containing 0.05% sodium azide and up to 5% trehalose

Reference Data

Target NameHomo sapiens parvin, alpha (PARVA)
Alternative NameCH-ILKBP; MXRA2
Database LinkNP_060692
Entrez Gene 55742 Human
Function
Related Pathway Focal adhesion

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

PARVA Elisa with 1H2 Capture (TA600346) and 3H2 Detection (TA700343) Antibodies. Substrate used: Recombinant Human PARVA (TP305086)
spacer
PARVA Luminex Elisa with 1H2 Capture (TA600346) and 3H2 Detection (TA700343) Antibodies. Substrate used: Recombinant Human PARVA (TP305086)
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title